3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
venetoclax
18
Rituximab
14
ibrutinib
13
acalabrutinib
11
obinutuzumab
10
Specimen Handling
10
Cyclophosphamide
9
Biopsy
9
zanubrutinib
8
pirtobrutinib
6
Magnetic Resonance Spectroscopy
5
Lenalidomide
5
idelalisib
4
fludarabine phosphate
4
Cyclosporine
4
CT-P10
4
Bendamustine Hydrochloride
4
ARQ531
4
Whole-Body Irradiation
3
Vincristine
3
Sirolimus
3
Prednisone
3
Mycophenolic Acid
3
Doxorubicin
3
tafasitamab
2
pembrolizumab
2
fludarabine
2
Immunoglobulins
2
Disulfides
2
Cyclosporins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
2C4 antibody
×
30 days
×
Clear all
No trials found.